Literature DB >> 19770729

Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.

Kenneth J Mandell1, Kathryn A Colby.   

Abstract

PURPOSE: The purpose of this study was to report a case of Phomopsis fungal keratitis that was diagnosed 2 months after a rose thorn injury that occurred while gardening.
METHODS: The authors conducted a retrospective case report with literature review.
RESULTS: Deep stromal keratitis with extension of hyphae through Descemet's membrane was treated by therapeutic keratoplasty combined with oral and topical antifungal medications. The causative organism, a Phomopsis species, was identified by culture of the surgical specimens. Phomopsis, a plant fungus, has not been previously reported as a cause of human fungal keratitis. One year after the initial surgery, visual rehabilitation was accomplished with a repeat cornea transplant and cataract extraction with return of vision to 20/25.
CONCLUSIONS: Advanced fungal keratitis can be successfully treated by a combination of surgery to debulk the infectious organisms and pre- and postoperative medical therapy. Prompt recognition of fungal keratitis will increase the likelihood of cure. Phomopsis species, ubiquitous plant fungi, can cause infectious keratitis in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19770729     DOI: 10.1097/ICO.0b013e31819839e6

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

1.  Therapeutic penetrating keratoplasty for infectious and non-infectious corneal ulcers.

Authors:  Zuleyha Yalniz-Akkaya; Ayse Burcu; Emine Doğan; Mustafa Onat; Firdevs Ornek
Journal:  Int Ophthalmol       Date:  2014-03-21       Impact factor: 2.031

2.  Excisional keratectomy combined with focal cryotherapy and amniotic membrane inlay for recalcitrant filamentary fungal keratitis: A retrospective comparative clinical data analysis.

Authors:  Yingxin Chen; Minghong Gao; Joshua K Duncan; Di Ran; Denise J Roe; Michael W Belin; Mingwu Wang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

3.  Fungal scleral keratitis caused by Phomopsis phoenicicola.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Trilok J Parmar; Anshul I Arora; Darshini A Ganatra; Forum B Kayastha; Bharat K Ghodadra; Abhay R Vasavada
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

4.  Results of therapeutic penetrating keratoplasty for bacterial and fungal keratitis.

Authors:  Yusuf Koçluk; Emine Alyamaç Sukgen
Journal:  Int Ophthalmol       Date:  2016-10-08       Impact factor: 2.031

5.  Cutaneous infection by Diaporthe phaseolorum in Brazil.

Authors:  Antonella S Mattei; Cecília B Severo; Luciana S Guazzelli; Flávio M Oliveira; Josepa Gené; Josep Guarro; José Cano; Luiz Carlos Severo
Journal:  Med Mycol Case Rep       Date:  2013-04-08

6.  Soft Tissue Infection with Diaporthe phaseolorum in Heart Transplant Recipient with End-Stage Renal Failure.

Authors:  Julia C Howard; Kevin Chen; Anja Werno; Sarah Metcalf
Journal:  Emerg Infect Dis       Date:  2019-09-17       Impact factor: 6.883

7.  Clinical outcome after air-assisted manual deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment.

Authors:  Eiichi Uchio; Yusuke Saeki; Tomoko Tsukahara-Kawamura; Kazuaki Kadonosono; Hiroaki Ozaki
Journal:  Clin Ophthalmol       Date:  2019-09-26

8.  Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation.

Authors:  Abdurrahman Muhammad Fahmy; Mariam Hassan; Doaa Ahmed El-Setouhy; Saadia Ahmed Tayel; Abdulaziz Mohsen Al-Mahallawi
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Big bubble deep anterior lamellar keratoplasty for management of deep fungal keratitis.

Authors:  Hua Gao; Peng Song; Jose J Echegaray; Yanni Jia; Suxia Li; Man Du; Victor L Perez; Weiyun Shi
Journal:  J Ophthalmol       Date:  2014-07-01       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.